Cancer specialists are advocating for a trusted breast cancer test that helps patients decide on treatment. But one company, ...

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients ...

Aspiring German citizens must now pass a citizenship test, the Einbürgerungstest, a 33-question multiple-choice exam costing ...

New KushoAI Research paper argues that AI-native testing needs to move beyond faster test generation toward coverage judgment ...

Turkey's 25-year Iran gas contract expires in July 2026. More LNG, March strikes on South Pars, and a post-Halkbank payments ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

NASA tested the Orion spacecraft forward bay cover's ejection mechanism at the Neil Armstrong Test Facility in Sandusky, Ohio ...

The White House started development of the Golden Dome in 2025, citing the threat posed by missiles, including hypersonic ...

Innovative Defense Technologies was awarded a $157.2 million Navy contract for automated testing and re-testing support; The ...

Whether insurance is purchased through an agent or directly on a digital platform, experts say consumers should resist choosing a policy based solely on the lowest premium ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare ...